Kiromic Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Kiromic Biopharma, Inc. has filed 252 SEC EDGAR filings since 15 Nov 2019

SEC filing history

Showing 1-25 of 252 matching filings.

Per page
25
Current page
1
S-1/A File 333-284359

FORM S-1/A

Filing date
19 Feb 2025
Reporting date
Not listed
Next action
Verify source filing
8-K/A File 001-39619

FORM 8-K/A

Filing date
03 Feb 2025
Reporting date
28 Jan 2025
Next action
Verify source filing
SC 13G/A File 005-92643

SC 13G/A

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Aug 2024
Reporting date
23 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2024
Reporting date
19 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Aug 2024
Reporting date
13 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Jun 2024
Reporting date
12 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Jun 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Jun 2024
Reporting date
10 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Jun 2024
Reporting date
12 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .